Toreforant

From WikiMD's Wellness Encyclopedia

Toreforant is a drug that was under development for the treatment of rheumatoid arthritis and inflammatory bowel disease. It acts as a selective antagonist for the Histamine H4 receptor, which is a protein that is part of the class A family of G protein-coupled receptors.

History[edit | edit source]

Toreforant was developed by Pfizer, a multinational pharmaceutical corporation. The drug was in Phase II clinical trials for the treatment of rheumatoid arthritis and inflammatory bowel disease. However, the development was discontinued due to lack of efficacy.

Mechanism of Action[edit | edit source]

Toreforant acts as a selective antagonist for the Histamine H4 receptor. This receptor is involved in the regulation of inflammatory responses in the body. By blocking this receptor, Toreforant can potentially reduce inflammation and alleviate symptoms of diseases such as rheumatoid arthritis and inflammatory bowel disease.

Clinical Trials[edit | edit source]

Toreforant underwent Phase II clinical trials for the treatment of rheumatoid arthritis and inflammatory bowel disease. However, the trials did not show sufficient efficacy of the drug, leading to the discontinuation of its development.

See Also[edit | edit source]

Toreforant Resources
Wikipedia
WikiMD
Navigation: Wellness - Encyclopedia - Health topics - Disease Index‏‎ - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes

Search WikiMD

Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD

WikiMD's Wellness Encyclopedia

Let Food Be Thy Medicine
Medicine Thy Food - Hippocrates

WikiMD is not a substitute for professional medical advice. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.

Contributors: Prab R. Tumpati, MD